Oncology
 |
|
4 july 2019 22:00:55 |
| AIPAC: a Phase IIb study of eftilagimod alpha (IMP321 or LAG-3Ig) added to weekly paclitaxel in patients with metastatic breast cancer (Future Oncology) |
|
Tweet Future Oncology, Volume 15, Issue 17, Page 1963-1973, June 2019. |
| 176 viewsCategory: Oncology |
 IMpassion132 Phase III trial: atezolizumab and chemotherapy in early relapsing metastatic triple-negative breast cancer (Future Oncology)Veliparib: a new therapeutic option in ovarian cancer? (Future Oncology) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
